Last reviewed · How we verify

Canephron® N — Competitive Intelligence Brief

Canephron® N (Canephron® N) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal combination / Phytopharmaceutical. Area: Urology / Nephrology.

phase 3 Herbal combination / Phytopharmaceutical Urology / Nephrology Small molecule Live · refreshed every 30 min

Target snapshot

Canephron® N (Canephron® N) — Bionorica SE. Canephron N is a herbal combination that reduces inflammation and supports kidney and urinary tract function through diuretic and antimicrobial properties.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Canephron® N TARGET Canephron® N Bionorica SE phase 3 Herbal combination / Phytopharmaceutical
Iberogast® and Iberogast® N Iberogast® and Iberogast® N Hospital Vall d'Hebron marketed Herbal combination / Phytopharmaceutical

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal combination / Phytopharmaceutical class)

  1. Bionorica SE · 1 drug in this class
  2. Hospital Vall d'Hebron · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Canephron® N — Competitive Intelligence Brief. https://druglandscape.com/ci/canephron-n. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: